Combatting Emerging Drug Threats with Real-Time Data NASHVILLE, TN. (February 11, 2025) – Aegis Sciences Corporation, a leader in toxicology and healthcare services,...
New or Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription...
NASHVILLE, TN. (December 10, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased...
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
On May 30, 2024, The Center for Forensic Science Research & Education (CFSRE) published an alert regarding 2F-2oxo-PCE...
Sign up for the Aegis Newsletter